Andreas is an expert in the drafting and prosecution of patent applications, with expertise in software, telecommunications, medical devices, process engineering and mechanical engineering.
Mathys & Squire LLP
mathys-squire.com mathys-squire.comLawyers
Annabel has considerable experience representing and advising clients of all sizes in relation to drafting and prosecution, and managing patent portfolios. She is experienced in litigation and has successfully defended a high profile opposition at the European Patent Office relating to aircraft, and been involved in corresponding infringement and validity proceedings at the UK High Court.
Chris Hamer is one of the world’s leading chemistry attorneys and widely considered as an expert in the field of ionic liquids and related technologies, although his expertise extends to numerous chemistry related technology areas, in particular food chemistry, natural food supplements, biochemicals, polymers, materials sciences, absorbent articles, catalytic processes and petrochemical technologies.
Craig’s practice covers diverse biotechnological subject matter, with a particular focus on vaccines, diagnostics, gene therapy, therapeutic antibodies and peptides, and biofuels. Craig has significant experience of European and international patent prosecution, and coordinates global IP strategies for a range of clients including startups, SMEs, universities, large corporations and the UK Government.
Dani works for a number of large corporations, drafting and prosecuting patent applications, and managing their international patent portfolios. He advises on technology-based agreements and handles contentious infringement and validity matters. Dani heads up our specialist Israel practice after spending years working with Israeli clients and attorney firms based in Israel.
Harry is a UK Chartered trade mark and design attorney and has been practising since 2014. Harry has experience working with a range of clients, from SMEs to multinationals, in relation to trade mark and wider intellectual property (IP) matters around the world. He is a commercially-astute attorney having assisted many corporate clients in his role prior to joining the firm. Additionally, Harry’s main areas of practice are trade mark clearance, prosecution, contentious and post-registration matters, as well as portfolio management.
Helen deals with all aspects of trade mark work from clearance searches to enforcement issues. In particular she focuses on contentious matters and has handled numerous oppositions and cancellation actions before the UKIPO and EUIPO. Helen also has extensive expertise in filing and prosecuting trade marks before the UKIPO, EUIPO and the Madrid Protocol system and has handled a number of due diligence matters.
Helen’s direct clients include multinationals in television/broadcasting, consumer care goods, chemicals, manufacturing and a global licensing company, plus several charities. Their global locations and activities mean regular visits to Japan and the US.
James’ practice focuses on European Patent Office (EPO) prosecution and opposition work in the life sciences sector. He also has extensive experience with supplementary protection certificates (SPCs) and has prosecuted SPC applications covering a number of blockbuster drugs.
Jane Clark has over 30 years’ experience of drafting, prosecution, infringement, validity, commercialisation of IP and global IP strategy advice including Freedom to Operate, licensing advice, entitlement disputes and competitor monitoring. She has extensive experience in many technical areas including metrological devices, medical devices, network and communications technology, semiconductor process and integrated circuit technologies and consumer products particularly domestic appliances and personal care.
Jane also has significant experience in negotiating multinational Intellectual Property Agreements and Collaboration Agreements with high-tech companies and Universities. She also has many years’ experience of EPO hearings and recently successfully defended a patent considered of very high value by the client during Opposition Proceedings.
Juliet is a partner in Mathys & Squire’s life sciences team, working in the fields of molecular biology, pharmaceuticals and biotechnology. She is experienced in examination and opposition proceedings at the European Patent Office, as well as drafting, prosecution and management of global patent portfolios. She also advises clients on infringement, validity and freedom-to-operate matters. Juliet works in the fields of molecular biology, pharmaceuticals and biotechnology, and has particular experience in the areas of antibody technology, vaccine technology, protein and peptide based medicines, personalised medicine, recombinant gene expression and diagnostic assays.
Laura has experience in the drafting and prosecution of patent applications in the UK, Europe and worldwide, particularly in the fields of ionic liquids, composite materials, polymer chemistry, solar cells, medical stents and oil and gas technologies. She has also been involved in patent opposition work and has experience in the management of patent portfolios. Laura also has experience in filing and prosecuting registered community designs.
Margaret is a highly regarded Trade Mark Attorney and Solicitor. She has over 25 years’ experience and an impressive track record representing a diverse range of clients, including household multinational corporations, in the development, management and worldwide protection of their trade mark and design portfolios.
Her clients include well-known companies in the automotive, oil and gas, food and beverage, clothing, e-commerce, charity and technology sectors.
Margaret has extensive experience advising on brand name selection and clearance, trade mark prosecution and a full range of contentious work, including oppositions, cancellation actions and Uniform Domain Name Dispute Resolution Policy (UDRP) proceedings.
Margaret heads up our litigation team. Her background as a commercial solicitor, as well as her Higher Courts Litigation Certificate (which enables her to conduct intellectual property litigation proceedings before the IPEC and the High Court, as well as appeals to the Court of Appeal and Supreme Court) is invaluable in her conduct and settlement of contentious IP proceedings. She was a member of the team that secured one of the first pan-European trade mark injunctions for infringement of a Community trade mark and has successfully protected the interests of her clients in proceedings in the Intellectual Property Enterprise Court and the High Court. She also routinely advises on the settlement of contentious proceedings and drafts any necessary agreements to ensure that her clients can overcome conflicts in a manner which is both commercially and legally acceptable.
Martin MacLean’s principal practice areas include; drafting and global prosecution, defence and opposition, freedom-to-operate and strategic advice. In this regard, he has extensive experience in the conduct of hearings before the European Patent Office, having conducted over 100 hearings. Martin specialises in technologies such as the re-targeting of bacterial toxins, vaccines, expression systems, microbial detection assays, cytokine-based therapeutics, and agrochemicals, and represents clients ranging from UK Government and blue chip biotech companies through to spin-outs and start-ups.
Paul Cozens has over 30 years of experience in the IP profession, which includes a track record constructing from scratch a number of major patent portfolios in addition to carving out useful patent monopoly in difficult areas. He has also undertaken a number of critical infringement risk assessment assignments over an array of technical areas.
Paul’s clients span the engineering and software sectors, as well as blue chip names in the financial services sector, where he is at the forefront of developing techniques for procuring patent protection for business process inventions. He also acts for clients in the environmental technology sector, including in the areas of wind and distributed energy, and is handling an increasing volume of instructions in relation to the areas of AI and cryptocurrency.
Philippa has a substantial prosecution practice before the European Patent Office (EPO), and she is responsible for the coordination and strategic management of complex worldwide patent portfolios covering commercially significant products. Philippa is also highly experienced in the conduct of offensive and defensive opposition and appeal proceedings before the EPO. Other aspects of her practice include drafting, freedom to operate, and opinion work.
Philippa has particular expertise in handling inventions relating to antibodies and immunology; immunotoxin-based therapeutics; recombinant protein production and formulation; synthetic biology, gene editing, cloning, and sequencing technologies; rapid/bedside diagnostics; modified and thermostable enzymes; bone and cartilage regeneration; and vaccines. She acts for a diverse range of clients, including international biopharma and bioscience companies, SMEs, public sector organisations, and universities.
Sean is an expert in the drafting of intellectual property (IP) agreements, IP licences and in the drafting and prosecution of European and UK patent applications. His principal areas of technical expertise are electronics, medical devices, and software.